NCT03463720

Brief Summary

Extremity wounds and fractures constitute the majority of war-associated traumatic injuries, both for civilians and combatants. War-associated injuries are often contaminated with foreign material, leading to infection. Wound infections is considered a major risk to life and restoration of function in war-wounded patients surviving past the first hours. In a cohort study the investigators aim to assess whether the infection itself affects patient outcome (i.e. amputation, death) when comparing patients with and patients without infection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
843

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2012

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

February 22, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 13, 2018

Completed
Last Updated

March 13, 2018

Status Verified

February 1, 2018

Enrollment Period

1.6 years

First QC Date

February 22, 2018

Last Update Submit

March 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Amputation

    In-hospital extremity amputation. Upper or lower extremity, all levels.

    From hospital admission to discharge, an average of 15 days

Secondary Outcomes (1)

  • Death

    From hospital admission to discharge, an average of 15 days

Study Arms (1)

Extremity wound

Patients with extremity wounds. Infected and not infected patients will be compared.

Other: InfectedOther: Not infected

Interventions

Extremity wound, infected

Extremity wound

Extremity wounds, non-infected

Extremity wound

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients treated at the hospital in Peshawar between September 27, 2010 and May 9, 2012 that meet eligibility criteria.

You may qualify if:

  • Patients that have received treatment for war-associated extremity wounds
  • Patients that present at the hospital within 72 hours of injury
  • Patients with valid data on baseline wound status.

You may not qualify if:

  • Patients that are re-admitted during the study period, i.e. patients that received treatment during the study period and are later re-admitted will only be counted as one patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International Committee of the Red Cross hospital

Peshawar, Khyber Pakhtunkhwa, Pakistan

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Jonas Malmstedt, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 22, 2018

First Posted

March 13, 2018

Study Start

September 27, 2010

Primary Completion

May 9, 2012

Study Completion

May 9, 2012

Last Updated

March 13, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

The use of identification numbers will ensure anonymity of the data. All data will remain confidential throughout the data entry and analysis process by encryption. Individual patient data will not be distributed outside the study location, or appear in any report or publication.

Locations